United States T Cell Specific Surface Glycoprotein CD28 Market Report 2017

December 2017 | 98 pages | ID: U69424E46EBEN
QYResearch

Abstracts

In this report, the United States T Cell Specific Surface Glycoprotein CD28 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of T Cell Specific Surface Glycoprotein CD28 in these regions, from 2012 to 2022 (forecast).

United States T Cell Specific Surface Glycoprotein CD28 market competition by top manufacturers/players, with T Cell Specific Surface Glycoprotein CD28 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Atox Bio Ltd
• Bristol-Myers Squibb Co
• Five Prime Therapeutics Inc
• Johnson & Johnson
• TheraMAB LLC

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• FPT-155
• FR-104
• Lulizumab Pegol
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Plaque Psoriasis
• Solid Tumor
• Acute Renal Failure(ARF)
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States T Cell Specific Surface Glycoprotein CD28 Market Report 2017

1 T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 OVERVIEW

1.1 Product Overview and Scope of T Cell Specific Surface Glycoprotein CD28
1.2 Classification of T Cell Specific Surface Glycoprotein CD28 by Product Category
  1.2.1 United States T Cell Specific Surface Glycoprotein CD28 Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States T Cell Specific Surface Glycoprotein CD28 Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 FPT-155
  1.2.4 FR-104
  1.2.5 Lulizumab Pegol
  1.2.6 Others
1.3 United States T Cell Specific Surface Glycoprotein CD28 Market by Application/End Users
  1.3.1 United States T Cell Specific Surface Glycoprotein CD28 Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Plaque Psoriasis
  1.3.3 Solid Tumor
  1.3.4 Acute Renal Failure(ARF)
  1.3.5 Others
1.4 United States T Cell Specific Surface Glycoprotein CD28 Market by Region
  1.4.1 United States T Cell Specific Surface Glycoprotein CD28 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
  1.4.3 Southwest T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
  1.4.5 New England T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
  1.4.6 The South T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
  1.4.7 The Midwest T Cell Specific Surface Glycoprotein CD28 Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of T Cell Specific Surface Glycoprotein CD28 (2012-2022)
  1.5.1 United States T Cell Specific Surface Glycoprotein CD28 Sales and Growth Rate (2012-2022)
  1.5.2 United States T Cell Specific Surface Glycoprotein CD28 Revenue and Growth Rate (2012-2022)

2 UNITED STATES T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States T Cell Specific Surface Glycoprotein CD28 Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States T Cell Specific Surface Glycoprotein CD28 Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States T Cell Specific Surface Glycoprotein CD28 Average Price by Players/Suppliers (2012-2017)
2.4 United States T Cell Specific Surface Glycoprotein CD28 Market Competitive Situation and Trends
  2.4.1 United States T Cell Specific Surface Glycoprotein CD28 Market Concentration Rate
  2.4.2 United States T Cell Specific Surface Glycoprotein CD28 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers T Cell Specific Surface Glycoprotein CD28 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Region (2012-2017)
3.2 United States T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Region (2012-2017)
3.3 United States T Cell Specific Surface Glycoprotein CD28 Price by Region (2012-2017)

4 UNITED STATES T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States T Cell Specific Surface Glycoprotein CD28 Revenue and Market Share by Type (2012-2017)
4.3 United States T Cell Specific Surface Glycoprotein CD28 Price by Type (2012-2017)
4.4 United States T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate by Type (2012-2017)

5 UNITED STATES T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States T Cell Specific Surface Glycoprotein CD28 Sales and Market Share by Application (2012-2017)
5.2 United States T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Atox Bio Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bristol-Myers Squibb Co
  6.2.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Five Prime Therapeutics Inc
  6.3.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Johnson & Johnson
  6.4.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 TheraMAB LLC
  6.5.2 T Cell Specific Surface Glycoprotein CD28 Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 MANUFACTURING COST ANALYSIS

7.1 T Cell Specific Surface Glycoprotein CD28 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 T Cell Specific Surface Glycoprotein CD28 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of T Cell Specific Surface Glycoprotein CD28 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES T CELL SPECIFIC SURFACE GLYCOPROTEIN CD28 MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States T Cell Specific Surface Glycoprotein CD28 Sales Volume, Revenue Forecast (2017-2022)
11.2 United States T Cell Specific Surface Glycoprotein CD28 Sales Volume Forecast by Type (2017-2022)
11.3 United States T Cell Specific Surface Glycoprotein CD28 Sales Volume Forecast by Application (2017-2022)
11.4 United States T Cell Specific Surface Glycoprotein CD28 Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of T Cell Specific Surface Glycoprotein CD28
Figure United States T Cell Specific Surface Glycoprotein CD28 Market Size (K Pcs) by Type (2012-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Volume Market Share by Type (Product Category) in 2016
Figure FPT-155 Product Picture
Figure FR-104 Product Picture
Figure Lulizumab Pegol Product Picture
Figure Others Product Picture
Figure United States T Cell Specific Surface Glycoprotein CD28 Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of T Cell Specific Surface Glycoprotein CD28 by Application in 2016
Figure Plaque Psoriasis Examples
Table Key Downstream Customer in Plaque Psoriasis
Figure Solid Tumor Examples
Table Key Downstream Customer in Solid Tumor
Figure Acute Renal Failure(ARF) Examples
Table Key Downstream Customer in Acute Renal Failure(ARF)
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States T Cell Specific Surface Glycoprotein CD28 Market Size (Million USD) by Region (2012-2022)
Figure The West T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States T Cell Specific Surface Glycoprotein CD28 Sales Share by Players/Suppliers
Figure 2017 United States T Cell Specific Surface Glycoprotein CD28 Sales Share by Players/Suppliers
Figure United States T Cell Specific Surface Glycoprotein CD28 Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States T Cell Specific Surface Glycoprotein CD28 Revenue Share by Players/Suppliers
Figure 2017 United States T Cell Specific Surface Glycoprotein CD28 Revenue Share by Players/Suppliers
Table United States Market T Cell Specific Surface Glycoprotein CD28 Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market T Cell Specific Surface Glycoprotein CD28 Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States T Cell Specific Surface Glycoprotein CD28 Market Share of Top 3 Players/Suppliers
Figure United States T Cell Specific Surface Glycoprotein CD28 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers T Cell Specific Surface Glycoprotein CD28 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers T Cell Specific Surface Glycoprotein CD28 Product Category
Table United States T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs) by Region (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Sales Share by Region (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Share by Region (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Region in 2016
Table United States T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Revenue Share by Region (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Revenue Market Share by Region in 2016
Table United States T Cell Specific Surface Glycoprotein CD28 Price (USD/Pcs) by Region (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs) by Type (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Sales Share by Type (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Share by Type (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Type in 2016
Table United States T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of T Cell Specific Surface Glycoprotein CD28 by Type (2012-2017)
Figure Revenue Market Share of T Cell Specific Surface Glycoprotein CD28 by Type in 2016
Table United States T Cell Specific Surface Glycoprotein CD28 Price (USD/Pcs) by Types (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate by Type (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs) by Application (2012-2017)
Table United States T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Market Share by Application in 2016
Table United States T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate by Application (2012-2017)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate by Application (2012-2017)
Table Atox Bio Ltd Basic Information List
Table Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2012-2017)
Figure Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales Market Share in United States (2012-2017)
Figure Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Co Basic Information List
Table Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Revenue Market Share in United States (2012-2017)
Table Five Prime Therapeutics Inc Basic Information List
Table Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2012-2017)
Figure Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales Market Share in United States (2012-2017)
Figure Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Revenue Market Share in United States (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2012-2017)
Figure Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales Market Share in United States (2012-2017)
Figure Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Revenue Market Share in United States (2012-2017)
Table TheraMAB LLC Basic Information List
Table TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales Growth Rate (2012-2017)
Figure TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales Market Share in United States (2012-2017)
Figure TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of T Cell Specific Surface Glycoprotein CD28
Figure Manufacturing Process Analysis of T Cell Specific Surface Glycoprotein CD28
Figure T Cell Specific Surface Glycoprotein CD28 Industrial Chain Analysis
Table Raw Materials Sources of T Cell Specific Surface Glycoprotein CD28 Major Players/Suppliers in 2016
Table Major Buyers of T Cell Specific Surface Glycoprotein CD28
Table Distributors/Traders List
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States T Cell Specific Surface Glycoprotein CD28 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Volume (K Pcs) Forecast by Type in 2022
Table United States T Cell Specific Surface Glycoprotein CD28 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Volume (K Pcs) Forecast by Application in 2022
Table United States T Cell Specific Surface Glycoprotein CD28 Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States T Cell Specific Surface Glycoprotein CD28 Sales Volume Share Forecast by Region (2017-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Volume Share Forecast by Region (2017-2022)
Figure United States T Cell Specific Surface Glycoprotein CD28 Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources